ライフサイエンスコーパス: vagus nerve stimulation

1 ster headache (galcanezumab and non-invasive vagus nerve stimulation).

2 ms of enhancing NTS neuronal activity during vagus nerve stimulation.

3 nd existing bioelectronic therapies, such as vagus nerve stimulation.

4 red for inhibition of cytokine production by vagus nerve stimulation.

5 r functional inhibition of TNF production by vagus nerve stimulation.

6 r requirements significantly decreased after vagus nerve stimulation.

7 of gut Lactobacillus species in response to vagus nerve stimulation.

8 A total of 84 vagus nerve stimulations (10 s each) have been performed

9 y lung inflation (7.5 cm H2O) or mimicked by vagus nerve stimulation (50 Hz).

10 ecause preclinical evidence shows electrical vagus nerve stimulation accelerates clotting to reduce h

11 The place of vagus nerve stimulation among antiepileptic drugs and ot

12 , with the carrageenan air pouch model, both vagus nerve stimulation and cholinergic agonists signifi

13 Vagus nerve stimulation and pulsed ultrasound activate t

14 eloped a method of transcutaneous mechanical vagus nerve stimulation and then investigated whether th

15 erve stimulation (SNS) and right and/or left vagus nerve stimulation and was compared with DOR during

16 receive electrical, transcutaneous, or sham vagus nerve stimulation and were followed for survival o

17 allosotomy), neuromodulation techniques (eg, vagus nerve stimulation), and dietary interventions repr

18 therapies are available, including surgery, vagus nerve stimulation, and deep brain stimulation.

19 e association between temporal lobe surgery, vagus nerve stimulation, and other non-pharmacological t

20 The anti-inflammatory effects of vagus nerve stimulation are well known.

21 animals, could help to explain the effect of vagus nerve stimulation as a treatment for headache diso

22 ne hemorrhage and thrombosis models, we show vagus nerve stimulation bypasses the factor VIII deficie

23 Vagus nerve stimulation can ameliorate autoimmune diseas

24 Our results demonstrate that noninvasive vagus nerve stimulation can significantly reduce insomni

25 te that bilateral autonomic activity (SNS or vagus nerve stimulation) cause reversible shifts of apex

26 Here, we use brief bursts of closed-loop vagus nerve stimulation (CL-VNS) delivered during rehabi

27 -focused training with real-time closed-loop vagus nerve stimulation (CLV) to enhance synaptic plasti

28 epeatedly pairing tones with brief pulses of vagus nerve stimulation completely eliminated the physio

29 With this background, we propose that vagus nerve stimulation could be used to improve organ v

30 on-invasive alternative to invasive cervical vagus nerve stimulation (cVNS) by activating vagal affer

31 ement anti-inflammatory therapy via cervical vagus nerve stimulation (cVNS) one should selectively ac

32 veral different approaches in use, including vagus nerve stimulation, deep brain stimulation of the t

33 All participants were implanted with a vagus nerve stimulation device.

34 Left-sided low-level vagus nerve stimulation did not change vagal nerve activ

35 Transcutaneous vagus nerve stimulation dose-dependently reduced systemi

36 ntiinflammatory pathway." Here, we show that vagus nerve stimulation during endotoxemia specifically

37 mulation, (3) surgical approaches, including vagus nerve stimulation, epidural electrical stimulation

38 Vagus nerve stimulation fails to control serum TNF level

39 Here we show that vagus nerve stimulation fails to inhibit tumor necrosis

40 irelessly powered and controlled implants in vagus nerve stimulation for pigs.

41 US Food and Drug Administration approval of vagus nerve stimulation for recurrent treatment-resistan

42 s: 1) sepsis group (eight pigs), 2) sepsis + vagus nerve stimulation group (nine pigs), and 3) contro

43 Now nearly 5 years post-approval, vagus nerve stimulation has emerged as a major non-pharm

44 Vagus nerve stimulation has shown many benefits for dise

45 hese observations demonstrate that auricular vagus nerve stimulation holds promise for improving slee

46 This review evaluates the role of vagus nerve stimulation in light of recently published r

47 hange in the direction of DOR, but bilateral vagus nerve stimulation increased and reversed DOR to ba

48 n of nicotine, an alpha7 agonist that mimics vagus nerve stimulation, increases proinflammatory cytok

49 Axial stretch and vagus nerve stimulation induced cranial displacement of

50 Treatment with transcutaneous vagus nerve stimulation inhibited HMGB1 levels and impro

51 Electrical vagus nerve stimulation inhibits proinflammatory cytokin

52 Vagus nerve stimulation inhibits proinflammatory cytokin

53 Transcutaneous vagus nerve stimulation is an efficacious treatment for

54 Vagus nerve stimulation is routinely used in the clinic

55 We hypothesize that left-sided low-level vagus nerve stimulation (LL-VNS) can suppress sympatheti

56 tions for temporary neurotoxicity, low-level vagus nerve stimulation [LL-VNS], stellate ganglion bloc

57 Low-level transcutaneous vagus nerve stimulation (LLTS) suppresses inflammation i

58 The effects of periodic left vagus nerve stimulation (LVNS) on chemically-induced sei

59 This suggests that vagus nerve stimulation might provide a significant ther

60 nerve stimulation (low SOE), and noninvasive vagus nerve stimulation (moderate SOE).

61 The device was implanted to deliver vagus nerve stimulation (n = 12 animals) and a functiona

62 Non-invasive vagus nerve stimulation (nVNS), single-transcranial magn

63 vidence that the anti-fibrillatory effect of vagus nerve stimulation on the ventricle is mediated by

64 Studies of the effect of vagus nerve stimulation on ventricular myocardial functi

65 t may be exploited through either electrical vagus nerve stimulation or administration of alpha7 agon

66 Vagus nerve stimulation paired with exposure to conditio

67 Vagus nerve stimulation paired with rehabilitation is a

68 ic stroke is common and might be improved by vagus nerve stimulation paired with rehabilitation.

69 Vagus nerve stimulation partially or completely prevente

70 It is unclear how vagus nerve stimulation regulates leukocyte trafficking

71 Vagus nerve stimulation remains a promising, yet unprove

72 Vagus nerve stimulation significantly (P<0.01) decreased

73 Similarly, vagus nerve stimulation significantly attenuates neutrop

74 ene-related peptide antibodies, non-invasive vagus nerve stimulation, sphenopalatine ganglion stimula

75 In contrast to vagus nerve stimulation studies, no substantial cardiova

76 on celiac nerve abolishes TNF suppression by vagus nerve stimulation, suggesting that the cholinergic

77 Cervical vagus nerve stimulation suppressed power in the 8-12-Hz

78 Left-sided low-level vagus nerve stimulation suppresses stellate ganglion ner

79 Spatially selective vagus nerve stimulation (sVNS) offers a promising approa

80 Spatially selective vagus nerve stimulation (sVNS) presents a promising appr

81 Together, these results establish that vagus nerve stimulation targeting the inflammatory refle

82 Vagus nerve stimulation targets acetylcholine-producing

83 lammatory effect of transcutaneous auricular vagus nerve stimulation (taVNS) and its ability to promo

84 The efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) as a non-invasive method

85 tinuous noninvasive transcutaneous auricular vagus nerve stimulation (taVNS) during exposure to emoti

86 Transcutaneous auricular vagus nerve stimulation (taVNS) has been investigated as

87 Transcutaneous auricular vagus nerve stimulation (taVNS) has been proposed to act

88 Transcutaneous auricular vagus nerve stimulation (taVNS) has shown promise as a n

89 Transcutaneous auricular vagus nerve stimulation (taVNS) is a promising technique

90 Transcutaneous auricular vagus nerve stimulation (taVNS) offers a non-invasive al

91 nightly, bilateral, transcutaneous auricular vagus nerve stimulation (taVNS) on insomnia and mental h

92 Transcutaneous auricular vagus nerve stimulation (taVNS) targets subcutaneous axo

93 ared the effects of transcutaneous auricular vagus nerve stimulation (taVNS, Cerbomed Nemos) with sha

94 ndicate that there is significant benefit to vagus nerve stimulation therapy.

95 During right or left vagus nerve stimulation, there was no change in the dire

96 a clinical study evaluating the capacity of vagus nerve stimulation to control epilepsy.

97 hase studies have supported potential use of vagus nerve stimulation to deliver autonomic regulation

98 cessful application of a phasic, noninvasive vagus nerve stimulation to improve cognitive control and

99 uromodulation by non-invasive transcutaneous vagus nerve stimulation (tVNS) can improve exercise capa

100 Transcutaneous vagus nerve stimulation (tVNS) has been proposed to stim

101 Transcutaneous vagus nerve stimulation (tVNS) is a promising technique

102 jection fraction (HFpEF) that transcutaneous vagus nerve stimulation (tVNS) reduced cardiac fibrosis

103 Vagus nerve stimulation (up to four times daily) in RA p

104 (iVNS) and transcutaneous auricular (taVNS) vagus nerve stimulation using intracranial neurophysiolo

105 ical vagus nerve section, and during central vagus nerve stimulation (VAGSTIM).

106 to either rehabilitation paired with active vagus nerve stimulation (VNS group) or rehabilitation pa

107 Specifically, the authors demonstrate that vagus nerve stimulation (VNS) activates the cholinergic

108 The hypothesis that left vagus nerve stimulation (VNS) at the cervical level resu

109 ctive of this study was to determine whether vagus nerve stimulation (VNS) can enhance the consolidat

110 erve fibers was implicated in several failed vagus nerve stimulation (VNS) clinical trials by effecti

111 ation for motor dysfunction, the delivery of vagus nerve stimulation (VNS) combined with tactile reha

112 controls multiple organs of the GI tract and vagus nerve stimulation (VNS) could provide a means for

113 Vagus nerve stimulation (VNS) devices have gained widesp

114 Vagus nerve stimulation (VNS) during sensory and motor e

115 Studies have indicated that vagus nerve stimulation (VNS) enhances extinction learni

116 Vagus nerve stimulation (VNS) has been explored as a tre

117 Vagus nerve stimulation (VNS) has been shown to enhance

118 Vagus nerve stimulation (VNS) has been shown to exert ca

119 Vagus nerve stimulation (VNS) has been shown to limit im

120 Paired vagus nerve stimulation (VNS) has emerged as a promising

121 Vagus nerve stimulation (VNS) has emerged as a therapeut

122 Vagus nerve stimulation (VNS) has previously been shown

123 NCE STATEMENT Recent studies have implicated vagus nerve stimulation (VNS) in enhanced learning and m

124 nvasive studies demonstrated that continuous vagus nerve stimulation (VNS) in rodents can activate th

125 ential benefits and underlying mechanisms of Vagus Nerve Stimulation (VNS) in the treatment of Chroni

126 Vagus nerve stimulation (VNS) is a bioelectronic therapy

127 Vagus nerve stimulation (VNS) is a common treatment for

128 Vagus nerve stimulation (VNS) is a neuromodulation thera

129 ABSTRACT: Vagus nerve stimulation (VNS) is an emerging therapy for

130 Vagus nerve stimulation (VNS) is being used increasingly

131 Noninvasive, transcutaneous vagus nerve stimulation (VNS) is currently used as a tre

132 e immunity, and modulation of this reflex by vagus nerve stimulation (VNS) is effective in various in

133 Vagus nerve stimulation (VNS) is emerging as potential t

134 Vagus nerve stimulation (VNS) is thought to affect neura

135 Vagus nerve stimulation (VNS) is used for management of

136 Vagus nerve stimulation (VNS) is widely used to treat dr

137 Here, we use a chronic vagus nerve stimulation (VNS) mouse model to study the e

138 sought to investigate the effect of cervical vagus nerve stimulation (VNS) on cerebral blood flow (CB

139 m effects of episodic inspiratory-inhibitory vagus nerve stimulation (VNS) on phrenic nerve activity.

140 gate this, mice were subjected to electrical vagus nerve stimulation (VNS) or sham surgery at the cer

141 Vagus nerve stimulation (VNS) paired with extinction enh

142 Vagus nerve stimulation (VNS) paired with rehabilitation

143 Vagus nerve stimulation (VNS) paired with rehabilitation

144 he pilot study was to evaluate the effect of Vagus Nerve Stimulation (VNS) paired with sounds in chro

145 loped a novel strategy that uses closed-loop vagus nerve stimulation (VNS) paired with tactile rehabi

146 Recent research has shown that vagus nerve stimulation (VNS) paired with tones or with

147 eviously shown the safety and feasibility of vagus nerve stimulation (VNS) paired with upper-limb reh

148 nervation of multiple organs, and electrical vagus nerve stimulation (VNS) provides an adjunctive tre

149 We have previously shown that direct vagus nerve stimulation (VNS) reduces the slope of actio

150 evoked cardiac response to bipolar cervical vagus nerve stimulation (VNS) reflects a dynamic interac

151 ANN-controlled vagus nerve stimulation (VNS) significantly mitigated ma

152 Vagus nerve stimulation (VNS) suppresses inflammation an

153 Vagus nerve stimulation (VNS) therapy was shown to impro

154 Vagus nerve stimulation (VNS) treats patients with drug-

155 own promise as a non-invasive alternative to vagus nerve stimulation (VNS) with implantable devices,

156 ow that combining brief bursts of electrical vagus nerve stimulation (VNS) with motor or tactile reha

157 ion Registry investigated whether adjunctive vagus nerve stimulation (VNS) with treatment as usual in

158 We hypothesized that electrical vagus nerve stimulation (VNS) would suppress harmaline t

159 t peripheral nerve stimulation, specifically vagus nerve stimulation (VNS), can alter neural activity

160 and approved in refractory focal epilepsies: vagus nerve stimulation (VNS), deep brain stimulation of

161 investigate the effect of vagotomy (VGX) and vagus nerve stimulation (VNS), on the development and se

162 One potential treatment is vagus nerve stimulation (VNS), which activates the senso

163 Only vagus nerve stimulation (VNS), which continues to develo

164 ndotoxin to the same levels as implant-based vagus nerve stimulation (VNS).

165 Vagus-nerve stimulation (VNS) is licensed in several cou

166 Vagus nerve stimulation warrants clinical study as a the

167 In 2021, vagus nerve stimulation was approved by the FDA as an ad

168 nt large animal model of progressive sepsis, vagus nerve stimulation was associated with a number of

169 timulation frequency-dependent manner during vagus nerve stimulation, with comparable increases seen